secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K/A
Filed at:   2025-04-14T23:59:59+00:00
Accession:  0001213900-25-031593
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 1.01, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive Therapeutics corrects warrant expiration dates via 8-K/A amendment
----------------------------------------------------------------------------

- Filing corrects inadvertent clerical error in Expiration Date on Exhibits 4.2 and 4.3 (Amended Tranche B and C Warrants) from Original 8-K.
- No other changes made to Original Filing; all terms of Exchange Agreement and Amended Certificate of Designation remain unchanged.
- Original March 2024 event exchanged 43,649,000 Series A-2 Preferred shares for Series A-2 Prime Preferred and amended warrants with reduced share counts and revised exercise price of $1,000.
- Corrected exhibits reflect accurate expiration dates; no impact on conversion prices or aggregate exercise amounts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390025031593/0001213900-25-031593-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390025031593/ea0237290-8ka1_unicyc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-031593

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer